Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release Tacrolimus and Sirolimus in Kidney Transplantation
NCT07033858Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sirolimus in kidney transplant rejection and cytomegalovirus infection (CMV) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Kidney function at 1 year and Post-transplant viral Infections at 1 year. Started Mar 2025; status: recruiting.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejectioncytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07033858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07033858.